Pharmac plans to expand access to five medicines for various cancers and conditions, including lanreotide acetate for neuroendocrine cancer, bowel obstruction, and acromegaly.
Pharmac, NZ's drug-funding agency, plans to expand access to five medicines for various cancers and conditions. Proposals include funding lanreotide acetate for neuroendocrine cancer, bowel obstruction, and acromegaly, as well as widening eligibility for four other medicines treating blood, kidney, and lung cancers. This aims to improve treatment options for patients without existing alternatives.
July 12, 2024
3 Articles